And while correct, these suggestions assume that what works well for one person will work the same way for everyone else
NHEJ efficiency was measured by quantifying GFP positive cells on a BD FACSCalibur 48 h after I SceI transfection
1 GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023. These medications alter glucose metabolism, gastric motility and sympathetic tone, which may lead to unique uptake patterns on PET-CT
Consult a health care practitioner for use beyond 6 months
Before prescribing, clinicians should confirm appropriate indicationseither inadequately controlled type 2 diabetes or obesity with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities such as hypertension or dyslipidemia)
That gap in the conversation is worth closing, because the reasons a clinician might consider it go considerably further than sperm counts